Papers

1

Total Citations

15

H-Index

1

About

Dr. Tushar Tatineni is a leading researcher in radiation oncology, with a specialized focus on the application of advanced radiosurgical techniques for complex hepatobiliary malignancies. His most notable contribution is the pioneering prospective study on robotic radiosurgery for hepatocellular carcinoma (HCC) patients with portal vein thrombosis—a historically challenging condition with limited treatment options. This work, published in 2021 and garnering 15 citations, provided critical interim evidence that stereotactic body radiation therapy can offer safe and effective local control in this high-risk population, challenging conventional treatment paradigms. Dr. Tatineni’s research directly addresses a significant unmet clinical need, demonstrating how precision radiotherapy can improve outcomes for patients with advanced liver cancer. His findings have been influential in shaping multidisciplinary management strategies, offering a non-invasive alternative to systemic therapies. Through his rigorous clinical investigation, Dr. Tatineni continues to advance the frontier of radiation oncology, bridging the gap between technological innovation and tangible patient benefit.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
15 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Amrita Institute of Medical Sciences and Research Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago